The Brain Tumor Segmentation in Pediatrics (BraTS-PEDs) Challenge: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
- URL: http://arxiv.org/abs/2404.15009v4
- Date: Thu, 11 Jul 2024 18:29:03 GMT
- Title: The Brain Tumor Segmentation in Pediatrics (BraTS-PEDs) Challenge: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
- Authors: Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Deep Gandhi, Zhifan Jiang, Syed Muhammed Anwar, Jake Albrecht, Maruf Adewole, Udunna Anazodo, Hannah Anderson, Ujjwal Baid, Timothy Bergquist, Austin J. Borja, Evan Calabrese, Verena Chung, Gian-Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov, Ariana Familiar, Keyvan Farahani, Andrea Franson, Anurag Gottipati, Shuvanjan Haldar, Juan Eugenio Iglesias, Anastasia Janas, Elaine Johansen, Blaise V Jones, Neda Khalili, Florian Kofler, Dominic LaBella, Hollie Anne Lai, Koen Van Leemput, Hongwei Bran Li, Nazanin Maleki, Aaron S McAllister, Zeke Meier, Bjoern Menze, Ahmed W Moawad, Khanak K Nandolia, Julija Pavaine, Marie Piraud, Tina Poussaint, Sanjay P Prabhu, Zachary Reitman, Jeffrey D Rudie, Mariana Sanchez-Montano, Ibraheem Salman Shaikh, Nakul Sheth, Wenxin Tu, Chunhao Wang, Jeffrey B Ware, Benedikt Wiestler, Anna Zapaishchykova, Miriam Bornhorst, Michelle Deutsch, Maryam Fouladi, Margot Lazow, Leonie Mikael, Trent Hummel, Benjamin Kann, Peter de Blank, Lindsey Hoffman, Mariam Aboian, Ali Nabavizadeh, Roger Packer, Spyridon Bakas, Adam Resnick, Brian Rood, Arastoo Vossough, Marius George Linguraru,
- Abstract summary: CBTN--DIPGR-ASNR-MICCAI BraTS-PEDs challenge focused on pediatric brain tumors.
Five-year survival rate for high-grade gliomas in children is less than 20%.
- Score: 4.023596068202542
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. Here we present the CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge, focused on pediatric brain tumors with data acquired across multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. The CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge brings together clinicians and AI/imaging scientists to lead to faster development of automated segmentation techniques that could benefit clinical trials, and ultimately the care of children with brain tumors.
Related papers
- BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023 [44.64458075448]
We present the results of the BraTS-PEDs 2023 challenge, the first Brain Tumor (BraTS) challenge focused on pediatric brain tumors.
BraTS-PEDs 2023 aimed to evaluate volumetric segmentation algorithms for pediatric brain gliomas from magnetic resonance imaging.
The top-performing AI approaches for pediatric tumor analysis included ensembles of nnU-Net and Swin UNETR, Auto3DSeg, or nnU-Net with a self-supervised framework.
arXiv Detail & Related papers (2024-07-11T20:35:32Z) - Can GPT-4V(ision) Serve Medical Applications? Case Studies on GPT-4V for
Multimodal Medical Diagnosis [59.35504779947686]
GPT-4V is OpenAI's newest model for multimodal medical diagnosis.
Our evaluation encompasses 17 human body systems.
GPT-4V demonstrates proficiency in distinguishing between medical image modalities and anatomy.
It faces significant challenges in disease diagnosis and generating comprehensive reports.
arXiv Detail & Related papers (2023-10-15T18:32:27Z) - A multi-institutional pediatric dataset of clinical radiology MRIs by
the Children's Brain Tumor Network [6.562299138758103]
We provide a large-scale pediatric dataset of 23,101 multi-parametric MRI exams acquired through routine care for 1,526 brain tumor patients.
This includes longitudinal MRIs across various cancer diagnoses, with associated patient-level clinical information, digital pathology slides, as well as tissue genotype and omics data.
arXiv Detail & Related papers (2023-10-02T17:59:56Z) - The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs) [4.119582963064813]
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children.
The five-year survival rate for high-grade gliomas in children is less than 20%.
The BraTS-PEDs 2023 challenge focuses on the development of volumentric segmentation algorithms for pediatric brain glioma.
arXiv Detail & Related papers (2023-05-26T15:40:11Z) - A Pilot Study of Relating MYCN-Gene Amplification with
Neuroblastoma-Patient CT Scans [14.442730976318726]
We adopt multiple machine learning (ML) algorithms to predict the presence or absence of MYCN gene amplification.
The dataset is composed of retrospective CT images of 23 neuroblastoma patients.
CNN-based method uses pre-trained convolutional neural network, and radiomics-based method extracts radiomics features.
arXiv Detail & Related papers (2022-05-21T15:14:24Z) - Cross-Modality Deep Feature Learning for Brain Tumor Segmentation [158.8192041981564]
This paper proposes a novel cross-modality deep feature learning framework to segment brain tumors from the multi-modality MRI data.
The core idea is to mine rich patterns across the multi-modality data to make up for the insufficient data scale.
Comprehensive experiments are conducted on the BraTS benchmarks, which show that the proposed cross-modality deep feature learning framework can effectively improve the brain tumor segmentation performance.
arXiv Detail & Related papers (2022-01-07T07:46:01Z) - Improving the Segmentation of Pediatric Low-Grade Gliomas through
Multitask Learning [0.1199955563466263]
We developed a segmentation model trained on magnetic resonance imaging (MRI) of pediatric patients with low-grade gliomas (pLGGs)
The proposed model utilizes deep Multitask Learning (dMTL) by adding tumor's genetic alteration classifier as an auxiliary task to the main network.
arXiv Detail & Related papers (2021-11-29T21:12:47Z) - SpineOne: A One-Stage Detection Framework for Degenerative Discs and
Vertebrae [54.751251046196494]
We propose a one-stage detection framework termed SpineOne to simultaneously localize and classify degenerative discs and vertebrae from MRI slices.
SpineOne is built upon the following three key techniques: 1) a new design of the keypoint heatmap to facilitate simultaneous keypoint localization and classification; 2) the use of attention modules to better differentiate the representations between discs and vertebrae; and 3) a novel gradient-guided objective association mechanism to associate multiple learning objectives at the later training stage.
arXiv Detail & Related papers (2021-10-28T12:59:06Z) - TB-Net: A Tailored, Self-Attention Deep Convolutional Neural Network
Design for Detection of Tuberculosis Cases from Chest X-ray Images [66.93350009086132]
Tuberculosis remains a global health problem, and is the leading cause of death from an infectious disease.
There has been significant interest in artificial intelligence-based TB screening solutions for use in resource-limited scenarios.
We introduce TB-Net, a self-attention deep convolutional neural network tailored for TB case screening.
arXiv Detail & Related papers (2021-04-06T14:09:05Z) - A Global Benchmark of Algorithms for Segmenting Late Gadolinium-Enhanced
Cardiac Magnetic Resonance Imaging [90.29017019187282]
" 2018 Left Atrium Challenge" using 154 3D LGE-MRIs, currently the world's largest cardiac LGE-MRI dataset.
Analyse of the submitted algorithms using technical and biological metrics was performed.
Results show the top method achieved a dice score of 93.2% and a mean surface to a surface distance of 0.7 mm.
arXiv Detail & Related papers (2020-04-26T08:49:17Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.